Globus Medical: Q1 Earnings Insights - Globus Medical (NYSE:GMED)

Globus Medical GMED reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:15 PM.

Here's what investors need to know about the announcement.

Globus Medical missed estimated earnings by 10.64%, reporting an EPS of $0.42 versus an estimate of $0.47.

Revenue was up $3.21 million from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 0.14% drop in the share price the next day.

Here's a look at Globus Medical's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	0.47	0.45	0.44	0.37
EPS Actual	0.49	0.50	0.56	0.49
Revenue Estimate	243.52M	228.35M	224.64M	198.39M
Revenue Actual	250.02M	229.72M	251.02M	227.34M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Globus Medical management provided guidance for FY 2022, expecting earnings between $2.1 and $2.1 per share.

To track all earnings releases for Globus Medical visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.